Concepedia

Kim Van derpoorten

KV

Statistics

Publications

9

Citations

436

H-Index

9

Active since

1997

Affiliations

UCLouvain(Current)

KU Leuven

Rega Institute for Medical Research

University of Bologna

National Institutes of Health

Kim Van derpoorten is an author at UCLouvain specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1997–2004

9

Publications

9

Synthesis and Anticonvulsant Activity of 2(3<i>H</i>)-Benzoxazolone and 2(3<i>H</i>)-Benzothiazolone Derivatives

Huseyin Ucar, Kim Van derpoorten, S. Cacciaguerra et al. · Journal of Medicinal Chemistry · 1998 · 137 citations · Full text

, , +11

<i>N</i>-Succinyl-(β-alanyl-<scp>l</scp>-leucyl-<scp>l</scp>-alanyl-<scp>l</scp>-leucyl)doxorubicin:  An Extracellularly Tumor-Activated Prodrug Devoid of Intravenous Acute Toxicity

Anne-Marie Fernandez, Kim Van derpoorten, Luc Dasnois et al. · Journal of Medicinal Chemistry · 2001 · 77 citations

, , +17

Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer: application to doxorubicin and preliminary in vitro and in vivo studies.

André Trouet, A. Passioukov, Kim Van derpoorten et al. · PubMed · 2001 · 68 citations

, , +16

Anti-HIV activity of N-1-adamantyl-4-aminophthalimide

Kim Van derpoorten, Jan Balzarini, Erik De Clercq et al. · Biomedicine & Pharmacotherapy · 1997 · 50 citations

, , +8

2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives: Novel, potent and selective σ1 receptor ligands

H. UCAR, S. Cacciaguerra, Santi Spampinato et al. · European Journal of Pharmacology · 1997 · 31 citations

, , +14

1–5 of 9